ESC Premium Access

Why should cardiopulmonary exercise testing be routinely used for assessing patients with valvular heart disease?

Congress Presentation

About the speaker

Doctor Cristina Cortina Camarero

University Hospital Infanta Leonor, Madrid (Spain)
0 follower

9 more presentations in this session

Age distribution of valvular heart disease in China: from a national multicenter prospective cohort study

Speaker: Doctor H. Zhang (Beijing, CN)

Thumbnail

Trends in rheumatic heart disease in Egypt (2006-2018): data from the national rheumatic heart prevention and control program

Speaker: Doctor A. El Ghamrawy (Almahalla Alkobra, EG)

Thumbnail

Survival of people with valvular heart disease in the community (OxValve-Survive)

Speaker: Associate Professor S. Myerson (Oxford, GB)

Thumbnail

Identification of microRNAs in aortic valve calcification patients with bicuspid aortic valve

Speaker: Doctor Z. meng (Beijing, CN)

Thumbnail

Lipoprotein(a) and autotaxin in patients with stenotic atherosclerosis of coronary arteries and aortic valve stenosis

Speaker: Mr M. Ezhov (Moscow, RU)

Thumbnail

Access the full session

Poster Session 3 - Epidemiology, pathophysiology and particular aspects of valve disease

Speakers: Doctor C. Cortina Camarero, Doctor H. Zhang, Doctor A. El Ghamrawy, Associate Professor S. Myerson, Doctor Z. meng...
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk